Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?".

Gabriele Ceccarelli Katiuscia Nardi Francesca Marchesani

Pharmacol Res

Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Pneumology, Via Santa Lucia 2, Macerata, 62100, Italy.

Published: August 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239007	PMC
http://dx.doi.org/10.1016/j.phrs.2020.104933	DOI Listing

Publication Analysis

Top Keywords

letter editor

editor response

response article

article "could

"could il-17

il-17 represent

represent therapeutic

therapeutic target

target treatment

treatment and/or

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?".

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?